Sponsors primarily outsource to CROs to control operational and infrastructure costs. Although there are obvious benefits to outsourcing, it creates new challenges around quality, oversight, collaboration, and governance.
As organizations reach their digitization goals, they now are facing new challenges. Current healthcare systems are generally adequate at answering specific questions for end-users by may be limited in addressing more complex questions.
As the industry prepares for the new age of hybrid and decentralized trials there is a heightened focus on data (quality, volume and validity), metrics and operational efficiency. Learn more at SCOPE 2020.
With unrelenting pressures to rein in budgets and cycle times, stakeholders are turning to quality as a solution, starting with building it into study startup and bringing change to entrenched silos that stall trial operations.